411 related articles for article (PubMed ID: 29605736)
21. Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival.
Dadras SS; Paul T; Bertoncini J; Brown LF; Muzikansky A; Jackson DG; Ellwanger U; Garbe C; Mihm MC; Detmar M
Am J Pathol; 2003 Jun; 162(6):1951-60. PubMed ID: 12759251
[TBL] [Abstract][Full Text] [Related]
22. Pathways targeting tumor lymphangiogenesis.
Wissmann C; Detmar M
Clin Cancer Res; 2006 Dec; 12(23):6865-8. PubMed ID: 17145802
[TBL] [Abstract][Full Text] [Related]
23. Vascular endothelial growth factor C disrupts the endothelial lymphatic barrier to promote colorectal cancer invasion.
Tacconi C; Correale C; Gandelli A; Spinelli A; Dejana E; D'Alessio S; Danese S
Gastroenterology; 2015 Jun; 148(7):1438-51.e8. PubMed ID: 25754161
[TBL] [Abstract][Full Text] [Related]
24. The lymphatic system in clinically localized urothelial carcinoma of the bladder: morphologic characteristics and predictive value.
Bolenz C; Auer M; Ströbel P; Heinzelbecker J; Schubert C; Trojan L
Urol Oncol; 2013 Nov; 31(8):1606-14. PubMed ID: 22503575
[TBL] [Abstract][Full Text] [Related]
25. Immunomodulatory roles of lymphatic vessels in cancer progression.
Swartz MA
Cancer Immunol Res; 2014 Aug; 2(8):701-7. PubMed ID: 25092811
[TBL] [Abstract][Full Text] [Related]
26. Genetic ablation of SOX18 function suppresses tumor lymphangiogenesis and metastasis of melanoma in mice.
Duong T; Proulx ST; Luciani P; Leroux JC; Detmar M; Koopman P; Francois M
Cancer Res; 2012 Jun; 72(12):3105-14. PubMed ID: 22523034
[TBL] [Abstract][Full Text] [Related]
27. The lymphatic vasculature: An active and dynamic player in cancer progression.
Rezzola S; Sigmund EC; Halin C; Ronca R
Med Res Rev; 2022 Jan; 42(1):576-614. PubMed ID: 34486138
[TBL] [Abstract][Full Text] [Related]
28. Tumor lymphangiogenesis in transitional cell carcinoma of the upper urinary tract: association with clinicopathological features and prognosis.
Miyata Y; Kanda S; Ohba K; Nomata K; Eguchi J; Hayashida Y; Kanetake H
J Urol; 2006 Jul; 176(1):348-53. PubMed ID: 16753442
[TBL] [Abstract][Full Text] [Related]
29. Mechanisms and Clinical Significance of Tumor Lymphatic Invasion.
Fujimoto N; Dieterich LC
Cells; 2021 Sep; 10(10):. PubMed ID: 34685565
[TBL] [Abstract][Full Text] [Related]
30. Lymphatic function, lymphangiogenesis, and cancer metastasis.
Swartz MA; Skobe M
Microsc Res Tech; 2001 Oct; 55(2):92-9. PubMed ID: 11596154
[TBL] [Abstract][Full Text] [Related]
31. Prognostic significance of tumor-associated lymphangiogenesis in malignant melanomas of the conjunctiva.
Heindl LM; Hofmann-Rummelt C; Adler W; Bosch JJ; Holbach LM; Naumann GO; Kruse FE; Cursiefen C
Ophthalmology; 2011 Dec; 118(12):2351-60. PubMed ID: 21835473
[TBL] [Abstract][Full Text] [Related]
32. Lymphangiogenesis occurs in upper tract urothelial carcinoma and correlates with lymphatic tumour dissemination and poor prognosis.
Bolenz C; Fernández MI; Trojan L; Hoffmann K; Herrmann E; Steidler A; Weiss C; Ströbel P; Alken P; Michel MS
BJU Int; 2009 Apr; 103(8):1040-6. PubMed ID: 18990139
[TBL] [Abstract][Full Text] [Related]
33. Intratumoral lymphatics and lymphatic vessel invasion detected by D2-40 are essential for lymph node metastasis in bladder transitional cell carcinoma.
Ma Y; Hou Y; Liu B; Li X; Yang S; Ma J
Anat Rec (Hoboken); 2010 Nov; 293(11):1847-54. PubMed ID: 20730866
[TBL] [Abstract][Full Text] [Related]
34. Tumor lymphangiogenesis and new drug development.
Dieterich LC; Detmar M
Adv Drug Deliv Rev; 2016 Apr; 99(Pt B):148-160. PubMed ID: 26705849
[TBL] [Abstract][Full Text] [Related]
35. Prognostic value of lymphangiogenesis in supraglottic laryngeal carcinoma.
Lin JY; Li XY; Dong P; Nakashima T
J Laryngol Otol; 2011 Sep; 125(9):945-51. PubMed ID: 21774849
[TBL] [Abstract][Full Text] [Related]
36. Intraocular tumor-associated lymphangiogenesis a novel prognostic factor for ciliary body melanomas with extraocular extension?
Heindl LM; Hofmann TN; Adler W; Knorr HL; Holbach LM; Naumann GO; Kruse FE; Cursiefen C
Ophthalmology; 2010 Feb; 117(2):334-42. PubMed ID: 19892405
[TBL] [Abstract][Full Text] [Related]
37. Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling.
He Y; Kozaki K; Karpanen T; Koshikawa K; Yla-Herttuala S; Takahashi T; Alitalo K
J Natl Cancer Inst; 2002 Jun; 94(11):819-25. PubMed ID: 12048269
[TBL] [Abstract][Full Text] [Related]
38. [VEGF-C and lymphatic vessels: a double-edged sword in tumor development and metastasis].
Ndiaye PD; Pagès G
Med Sci (Paris); 2019 Feb; 35(2):132-137. PubMed ID: 30774080
[TBL] [Abstract][Full Text] [Related]
39. p19/Arf and p53 suppress sentinel lymph node lymphangiogenesis and carcinoma metastasis.
Ruddell A; Kelly-Spratt KS; Furuya M; Parghi SS; Kemp CJ
Oncogene; 2008 May; 27(22):3145-55. PubMed ID: 18059331
[TBL] [Abstract][Full Text] [Related]
40. Correlation between lymphangiogenesis and clinicopathological parameters in renal cell carcinoma.
Ozardili I; Guldur ME; Ciftci H; Bitiren M; Altunkol A
Singapore Med J; 2012 May; 53(5):332-5. PubMed ID: 22584974
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
